ECSP972049A - LACTAMA DERIVATIVES - Google Patents

LACTAMA DERIVATIVES

Info

Publication number
ECSP972049A
ECSP972049A ECSP972049A ECSP972049A EC SP972049 A ECSP972049 A EC SP972049A EC SP972049 A ECSP972049 A EC SP972049A EC SP972049 A ECSP972049 A EC SP972049A
Authority
EC
Ecuador
Prior art keywords
derivatives
lactama
antagonists
present
agonists
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Harry Ralph Howard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP972049 priority Critical patent/ECSP972049A/en
Publication of ECSP972049A publication Critical patent/ECSP972049A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a derivados de lactama, a procedimientos y a intermedios para su preparación, a composiciones farmacéuticas que los contienen y a su uso en medicina. Los compuestos de la presente invención incluyen agonistas y antagonistas selectivos de receptores de serotonina 1(5-HT 1), específicamente, de uno o de los dos receptores 5-HT1A y 5-HT1). Son útiles en el tratamiento o prevención de la migraña, depresión y otros transtornos para los que están indicados los agonistas o antagonistas de 5-HT1The present invention relates to lactam derivatives, to processes and to intermediates for their preparation, to pharmaceutical compositions containing them and to their use in medicine. The compounds of the present invention include selective serotonin 1 (5-HT 1) receptor agonists and antagonists, specifically, one or both of the 5-HT1A and 5-HT1 receptors). They are useful in the treatment or prevention of migraine, depression and other disorders for which 5-HT1 agonists or antagonists are indicated.

ECSP972049 1997-03-05 1997-03-05 LACTAMA DERIVATIVES ECSP972049A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP972049 ECSP972049A (en) 1997-03-05 1997-03-05 LACTAMA DERIVATIVES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP972049 ECSP972049A (en) 1997-03-05 1997-03-05 LACTAMA DERIVATIVES

Publications (1)

Publication Number Publication Date
ECSP972049A true ECSP972049A (en) 1998-02-13

Family

ID=42042882

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP972049 ECSP972049A (en) 1997-03-05 1997-03-05 LACTAMA DERIVATIVES

Country Status (1)

Country Link
EC (1) ECSP972049A (en)

Similar Documents

Publication Publication Date Title
GT199700107A (en) LACTAMS AND HETERO-CYCLIC IMIDES OF ARALQUILO AND ARAQUILIDENO
UA39168C2 (en) FLUORALCOXYPHENYL DERIVATIVES OF PIPERIDINE OR QINUCLIDINE, WHICH ARE ANTAGONISTS OF SUBSTANCE P AND PHARMACEUTICAL COMPOSITION BASED ON THEM
BG106142A (en) Glucocorticoid receptor modulators
BG101806A (en) INDOLE DERIVATIVES AS ANTAGONISTS OF 5-N RECEPTORS
NO20003550L (en) Pharmaceutical compositions and their use
DK0760811T3 (en) Imidazole derivatives as histamine receptor H3 modulators
ECSP941122A (en) DERIVATIVES OF 5-ARYLINDOLS
ATE172723T1 (en) TRYPTAMINE ANALOGAS, THEIR PREPARATION AND USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTS
DK0687251T3 (en) 1,3-dihydroindol-2-one derivatives substituted at the 3-position with a nitrogen group for use as vasopressin and / or ocytocin agonists and / or antagonists
DE69532162D1 (en) Cannabinoid receptor Antagonist
CA2360313A1 (en) Glucocorticoid receptor modulators
SE9702651D0 (en) Novel compounds
BR0015540A (en) Adenosine receptor antagonists and methods of preparing and using them
MX9304595A (en) DERIVATIVES OF 1,2,4-TRIAZOLA SUBSTITUTED IN 4
AR015446A1 (en) ANTIGONISTS OF VITRONECTINE RECEPTORS, PHARMACEUTICAL COMPOSITION CONTAINING THEM, PROCEDURE FOR PREPARATION, ITS USE FOR THE PREPARATION OF A MEDICINE AND INTERMEDIATE COMPOUNDS
AR024840A1 (en) 5HT1 COMPOUNDS FOR ANTIDEPRESSIVE THERAPY; PHARMACEUTICAL COMPOSITIONS AND ITS USE IN THE PREPARATION OF MEDICINES.
BR0015172A (en) New combination comprising a beta 2 adrenaline agonist (beta 2) and a leukotriene receptor antagonist
NO963331L (en) 5-Heteroarylindole derivatives as benzodiazepine receptor site agonists and antagonists
SE9702002D0 (en) Novel compounds
DE69819742D1 (en) INDOLDER DERIVATIVES AS 5-HT1B AND 5-HT1D AGONISTS
FR2690847B1 (en) COMPOSITIONS WITH AGONIST ACTIVITY OF SELECTIVE 5HT1 ANALOGUE RECEPTORS.
BR0011680A (en) Neuromedin b somatostatin receptor agonists, their use and pharmaceutical composition comprising the same
ECSP972049A (en) LACTAMA DERIVATIVES
Millan et al. Potentiation of fluoxetine-induced penile erections by combined blockade of 5-HT1A and 5-HT1B receptors
ITTO930661A1 (en) POLYAMIDE ACID DERIVATIVES WITH ANTI-GASTRINIC ACTIVITY, PROCEDURE FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE.